Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111423381B reveals a mild palladium-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Novel Pd-catalyzed method for chroman amides offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103922909B details a mild palladium-catalyzed fluorination route. This breakthrough offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel patent CN118459425B details high-yield synthesis of pyrrolidine-1-amine-dihydrochloride. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104072495A details a high-yield Aaptamine synthesis route offering significant cost reduction in pharmaceutical intermediates manufacturing and improved supply chain reliability.
Patent CN106748964B details copper-promoted cyclopropanation for pharmaceutical intermediates. Offers mild conditions and high yields for scalable manufacturing supply chains.
Patent CN118619879A reveals a novel Rh-catalyzed route for trifluoromethyl enaminones. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Offers cost reduction in fine chemical manufacturing and reliable pharmaceutical intermediates supplier capabilities.
Advanced synthesis of Tolvaptan intermediates via CN105753735B. Offers cost reduction in API manufacturing with high purity and scalable routes for global supply chains.
Patent CN113121462B reveals a metal-free, azide-safe route for 5-trifluoromethyl-1,2,3-triazoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN107686471B reveals a greener Feloxicib synthesis route avoiding toxic thioethers. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN103113308B reveals iodine-catalyzed route. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN115215810B reveals catalyst-free heating method for triazoles. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering significant cost reduction in API manufacturing and scalable production.
Patent CN110483387B reveals efficient Cu-catalyzed route. High purity, scalable process for pharma intermediates reducing manufacturing complexity.
Patent CN115286578B reveals metal-free synthesis for trifluoromethyl pyrazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method for halogenated oxaallylamines. Reduces steps, improves yield for beta-blocker intermediates. Ideal for API manufacturing cost reduction.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazoles. Offers cost reduction and scalability for pharma intermediates.
Patent CN110183341A reveals stable thioester reagents for 1,2-dicarbonyl synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing intermediates.
Patent CN115215810B reveals catalyst-free synthesis for high-purity triazole intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.